Insider · CIK 0001651537

Erlander Mark

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001651537

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-03-11	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+758K sh	—	—	2,925,098
2024-03-07	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+510K sh	—	—	2,170,310
2023-03-15	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+482K sh	—	—	1,664,477
2022-11-25	CRDFCardiff Oncology, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$1.43	+$14.3K	24,481
2022-03-09	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+370K sh	—	—	1,185,400
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+435K sh	—	—	815,272
2021-03-23	CRDFCardiff Oncology, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+965 sh	$10.34	+$9,979.741	14,481
2021-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+260 sh	—	—	13,629
2021-01-02	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−113 sh	—	—	13,516
2021-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−260 sh	—	—	0
2020-06-17	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+221K sh	—	—	380,200
2020-05-14	CRDFCardiff Oncology, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+6,993 sh	$1.43	+$9,999.99	13,369
2020-01-03	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−552 sh	—	—	6,231
2020-01-03	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−116 sh	—	—	6,376
2020-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+261 sh	—	—	6,492
2020-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−261 sh	—	—	260
2020-01-01	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,250 sh	—	—	6,783
2020-01-01	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,250 sh	—	—	521
2019-10-01	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,250 sh	—	—	5,999
2019-10-01	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−466 sh	—	—	5,533
2019-10-01	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,250 sh	—	—	1,771
2019-07-01	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,250 sh	—	—	5,210
2019-07-01	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−461 sh	—	—	4,749
2019-07-01	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,250 sh	—	—	3,021
2019-06-20	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+134K sh	—	—	158,959
2019-04-01	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,250 sh	—	—	4,419
2019-04-01	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−459 sh	—	—	3,960
2019-04-01	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,250 sh	—	—	4,271
2019-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,563 sh	—	—	19,708
2019-01-02	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−698 sh	—	—	19,010
2019-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,563 sh	—	—	33,125
2019-01-01	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+7,500 sh	—	—	21,180
2019-01-01	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−3,035 sh	—	—	18,145
2019-01-01	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−7,500 sh	—	—	34,688
2018-10-01	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+7,500 sh	—	—	16,411
2018-10-01	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,731 sh	—	—	13,680
2018-10-01	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−7,500 sh	—	—	42,188
2018-07-24	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+45K sh	—	—	49,688
2018-01-30	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+90K sh	—	—	147,297
2018-01-30	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−42.9K sh	—	—	104,367
2018-01-30	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−90K sh	—	—	56,250
2018-01-23	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+672K sh	—	—	1,782,189
2018-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+18.8K sh	—	—	66,855
2018-01-02	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,558 sh	—	—	57,297
2018-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−18.8K sh	—	—	146,250
2018-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+18.8K sh	—	—	66,801
2018-01-02	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,558 sh	—	—	57,243
2018-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−18.8K sh	—	—	146,250
2017-09-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+30K sh	—	—	61,033
2017-09-02	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.9K sh	—	—	48,051

Recent filings

Accepted (ET)
Mar 134
Erlander Mark0000950170-25-038694
SEC(opens sec.gov)
Mar 74
Erlander Mark0001628280-24-009745
SEC(opens sec.gov)
Mar 164
Erlander Mark0001628280-23-008354
SEC(opens sec.gov)
Nov 294
Erlander Mark0001628280-22-030946
SEC(opens sec.gov)
Mar 104
Erlander Mark0001628280-22-005790
SEC(opens sec.gov)
Jun 144
Erlander Mark0001628280-21-012172
SEC(opens sec.gov)
Mar 234
Erlander Mark0001628280-21-005335
SEC(opens sec.gov)
Jan 54
Erlander Mark0001628280-21-000060
SEC(opens sec.gov)
Jun 194
Erlander Mark0001104659-20-075234
SEC(opens sec.gov)
May 184
Erlander Mark0001104659-20-063184
SEC(opens sec.gov)
Jan 34
Erlander Mark0001104659-20-000872
SEC(opens sec.gov)
Jan 34
Erlander Mark0001104659-20-000881
SEC(opens sec.gov)
Oct 34
Erlander Mark0001104659-19-052973
SEC(opens sec.gov)

Companies

Cardiff Oncology, Inc.Director, Chief Executive OfficerCRDF

Address

C/O CARDIFF ONCOLOGY, INC. 11055 FLINTKOTE AVE

SAN DIEGO, CA, 92121